Improved biocompatibility and pharmacokinetics of silica nanoparticles by means of a lipid coating: a multimodality investigation.
about
Biosafe nanoscale pharmaceutical adjuvant materialsOverview about the localization of nanoparticles in tissue and cellular context by different imaging techniquesQuantum dots as a platform for nanoparticle drug delivery vehicle designChemical basis of interactions between engineered nanoparticles and biological systemsDressing up Nanoparticles: A Membrane Wrap to Induce Formation of the Virological Synapse.Nanoparticles for biomedical imaging: fundamentals of clinical translationAmine modification of nonporous silica nanoparticles reduces inflammatory response following intratracheal instillation in murine lungsInorganic nanocrystals as contrast agents in MRI: synthesis, coating and introduction of multifunctionality.Nanodisco balls: control over surface versus core loading of diagnostically active nanocrystals into polymer nanoparticlesIn vivo evaluation of (64)Cu-labeled magnetic nanoparticles as a dual-modality PET/MR imaging agent.Multimodality imaging probes: design and challenges.Glycosphingolipid-functionalized nanoparticles recapitulate CD169-dependent HIV-1 uptake and trafficking in dendritic cellsNanotargeted radionuclides for cancer nuclear imaging and internal radiotherapyToxicity evaluation of Gd2O3@SiO2 nanoparticles prepared by laser ablation in liquid as MRI contrast agents in vivo.In vivo immunotoxicity of SiO2@(Y0.5Gd0.45Eu0.05)2O3 as dual-modality nanoprobesParamagnetic liposomes for molecular MRI and MRI-guided drug delivery.Tissue distribution and excretion kinetics of orally administered silica nanoparticles in rats.Integrin targeting for tumor optical imagingGadolinium chloride augments tumor-specific imaging of targeted quantum dots in vivoBiodistribution of PAMAM dendrimer conjugated magnetic nanoparticles in mice.Inorganic-organic hybrid nanomaterials for therapeutic and diagnostic imaging applications.Folate receptor-targeted fluorescent paramagnetic bimodal liposomes for tumor imaging.Silica nanoparticles as substrates for chelator-free labeling of oxophilic radioisotopes.Global transcriptomic analysis of model human cell lines exposed to surface-modified gold nanoparticles: the effect of surface chemistry.Nanoparticle PEGylation for imaging and therapy.Use of a lipid-coated mesoporous silica nanoparticle platform for synergistic gemcitabine and paclitaxel delivery to human pancreatic cancer in miceSystematic in vitro toxicological screening of gold nanoparticles designed for nanomedicine applicationsIn vivo targeting of inflammation-associated myeloid-related protein 8/14 via gadolinium immunonanoparticles.A critical review of lipid-based nanoparticles for taxane delivery.Determining the pharmacokinetics and long-term biodistribution of SiO2 nanoparticles in vivo using accelerator mass spectrometry.Nanostructured porous Si-based nanoparticles for targeted drug deliveryCarbohydrate-conjugated fluorescent silica nanoprobes for selective detection of galectin-1 and prostate cancer cells.Lipid-Mediated Targeting with Membrane-Wrapped Nanoparticles in the Presence of Corona FormationMultifunctional dendrimer-based nanoparticles for in vivo MR/CT dual-modal molecular imaging of breast cancer.Membrane mimetic surface functionalization of nanoparticles: methods and applicationsSilica-based nanoprobes for biomedical imaging and theranostic applications.Nanotechnology in medical imaging: probe design and applications.Modified natural nanoparticles as contrast agents for medical imaging.Multifunctional imaging nanoprobesTowards nanomedicines: design protocols to assemble, visualize and test carbon nanotube probes for multi-modality biomedical imaging.
P2860
Q26829798-BD9BAE9A-64E2-43D0-8956-4C66F16EB58EQ26853219-F1C80BDE-2E3A-4E36-B72C-3B5F9D952FE2Q26996556-314AD473-E7BD-4EDC-A1E3-BEAE074161E7Q27021154-F942EE5D-604E-42EE-A2D6-3CDAF6B3D005Q27300214-1C482D24-4891-44CC-B4CC-73A94EAA2D02Q28385644-FAC7475A-93AA-4C96-8888-72D7A2D20F69Q28397622-62C03944-D5E3-49BF-B3EC-92F7CA570F0FQ30585395-C9F48D30-0AC4-416D-A5E5-3F62296DA10AQ30587599-93BB44E7-AE7B-4568-A64F-01A2260708B9Q33833089-C9A2BB80-DF18-49D1-8F3A-33080FFFAC18Q33884695-36E02A76-0DBF-42A6-9619-CDC1ED6F9058Q33943688-6847489E-3BA5-46B3-A1A2-73306E5613FEQ34089324-7C83856B-A019-4481-88B1-2A79495EA299Q34110059-B1756384-B00D-4D1E-A704-26FB5F6F94CFQ34158423-75AD91D2-AAE3-4BC4-BB38-31DF33FD8845Q34736942-6D04F6FE-6C7D-45B7-B59C-5E8D52F0E8ECQ34787883-D998D353-76AB-44CD-91D6-5292A129D921Q34912662-0012EBE2-95FA-4FD4-9792-03C52F4B14E6Q34961311-DB056C09-3B57-4BFF-A66E-1FF4A7CB3B53Q35052810-BCB44FA2-C6C0-41B0-AA81-2A576629F829Q35091821-7B2BE7F9-2FF6-4606-A82D-146FF51A327DQ35488256-FC90E0AC-E048-481C-8BFA-4D08089972B5Q35537978-1E7AF7DA-518B-46F2-8AC5-6D548AADAA54Q35545338-38A3FCE7-D781-4AAE-9B13-706EEBFECB19Q35553193-C49EDA8A-9886-412D-94FF-CDC3986DAE70Q35556561-7C5A5685-5A98-42ED-931B-F2418DC17F61Q35648763-77114971-DB7F-48E2-BF7C-D44214792223Q35947472-0BE5550F-DD12-4929-A926-C817CD9907AEQ36360764-DF3D7524-19EB-4BA3-B08E-29F7B773743DQ36402145-91B61B75-2580-4A33-BEB1-B03CBCC6C4BEQ36597461-2E2B33DD-490A-4518-82E2-769FE04C32C4Q36786004-B5EBAD81-4A3F-4F29-AE34-02273A54DF6CQ36828184-2EFB9AC1-08B8-4E7A-A85F-A6723A391808Q37042284-F88F9A3A-2E48-40B0-AC42-3F31302475A3Q37060172-F0C0E95C-0255-48AB-88B2-18D4E39A98C6Q37182903-187F217C-8C57-4AC5-A8E0-811D887424F0Q37341362-99C0F99A-123C-4E69-818F-97575E3EDB45Q37629944-E8CD8BA1-75B0-42CD-93AB-80ECCF2633C0Q37663915-6C886F5F-2BE2-4E21-9975-307DD3984622Q37770188-23F27621-9C53-4F0C-A991-61F99050B84F
P2860
Improved biocompatibility and pharmacokinetics of silica nanoparticles by means of a lipid coating: a multimodality investigation.
description
2008 nî lūn-bûn
@nan
2008 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Improved biocompatibility and ...... a multimodality investigation.
@ast
Improved biocompatibility and ...... a multimodality investigation.
@en
type
label
Improved biocompatibility and ...... a multimodality investigation.
@ast
Improved biocompatibility and ...... a multimodality investigation.
@en
prefLabel
Improved biocompatibility and ...... a multimodality investigation.
@ast
Improved biocompatibility and ...... a multimodality investigation.
@en
P2093
P50
P356
P1433
P1476
Improved biocompatibility and ...... a multimodality investigation.
@en
P2093
Cheuk Y Tang
Esad Vucic
Rolf Koole
Ronald E Gordon
Willem J M Mulder
Zahi A Fayad
P304
P356
10.1021/NL801596A
P407
P577
2008-07-12T00:00:00Z